December 04, 2025

HPV Testing Shift: New Screening Guidance

The American Cancer Society’s updated cervical cancer screening guideline introduces FDA-approved self-collected HPV testing and clearer exit criteria.

Conexiant

December 02, 2025

‘Liver Cancer Has Disappeared in Children’: But for How Long?

A review of the hepatitis B birth-dose recommendation examines vaccination practices, transmission risks, and potential impacts on newborn protection.

KFF Health News

December 01, 2025

Three Keys to Closing the Communication Gap

New ACOG statement outlines relationship-centered strategies to build trust and improve outcomes, particularly for marginalized patients.

Conexiant

November 20, 2025

Cervical Cancer: SLNB Alone vs Lymphadenectomy

In a Chinese phase III trial (PHENIX) reported in the New England Journal of Medicine, Tu et al found that sentinel lymph-node biopsy alone was noninferior in disease-free survival vs lymphadenectomy ...

The ASCO Post

November 18, 2025

‘Designed to Scare People’? New Contraception Data

Hormonal contraception shows overall safety with a modest, short-term rise in breast cancer risk.

KFF Health News

August 11, 2025

Why Turning 26 Jeopardizes Health Coverage

A growing number of young Americans lose affordable health insurance at age 26, facing complex Affordable Care Act marketplaces, rising costs, and limited coverage options.

KFF Health News

August 12, 2025

Advanced-Practice Providers Filling Rural ER Gaps

Rural emergency rooms across the U.S. are increasingly staffed by physician assistants and nurse practitioners instead of physicians, raising debates over care quality, staffing shortages, and access to emergency services.

KFF Health News

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News